XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock Issued
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2023   136,041,000      
Balance at beginning of period at Dec. 31, 2023 $ 671,645 $ 14 $ 653,174 $ 54,782 $ (36,325)
Beginning balance, treasury stock (in shares) at Dec. 31, 2023         (5,678,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grants of restricted stock (in shares)   383,000      
Stock-based compensation 512   512    
Purchase of treasury stock (in shares)         (2,000)
Purchase of treasury stock (17)       $ (17)
Common stock dividend declared (14,349)     (14,349)  
Net income 16,227     16,227  
Balance at ending of period (in shares) at Mar. 31, 2024   136,424,000      
Balance at ending of period at Mar. 31, 2024 674,018 $ 14 653,686 56,660 $ (36,342)
Ending balance, treasury stock (in shares) at Mar. 31, 2024         (5,680,000)
Balance at beginning of period (in shares) at Dec. 31, 2023   136,041,000      
Balance at beginning of period at Dec. 31, 2023 671,645 $ 14 653,174 54,782 $ (36,325)
Beginning balance, treasury stock (in shares) at Dec. 31, 2023         (5,678,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 21,327        
Balance at ending of period (in shares) at Jun. 30, 2024   136,424,000      
Balance at ending of period at Jun. 30, 2024 665,321 $ 14 654,269 47,380 $ (36,342)
Ending balance, treasury stock (in shares) at Jun. 30, 2024         (5,680,000)
Balance at beginning of period (in shares) at Mar. 31, 2024   136,424,000      
Balance at beginning of period at Mar. 31, 2024 674,018 $ 14 653,686 56,660 $ (36,342)
Beginning balance, treasury stock (in shares) at Mar. 31, 2024         (5,680,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 583   583    
Common stock dividend declared (14,381)     (14,381)  
Net income 5,101     5,101  
Balance at ending of period (in shares) at Jun. 30, 2024   136,424,000      
Balance at ending of period at Jun. 30, 2024 $ 665,321 $ 14 654,269 47,380 $ (36,342)
Ending balance, treasury stock (in shares) at Jun. 30, 2024         (5,680,000)
Balance at beginning of period (in shares) at Dec. 31, 2024 136,417,677 136,418,000      
Balance at beginning of period at Dec. 31, 2024 $ 635,353 $ 14 655,472 16,047 $ (36,180)
Beginning balance, treasury stock (in shares) at Dec. 31, 2024 (5,683,921)       (5,684,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grants of restricted stock (in shares)   413,000      
Forfeitures of restricted stock (in shares)   (7,000)      
Stock-based compensation $ 653   653    
Purchase of treasury stock (in shares)         (3,000)
Purchase of treasury stock (16)       $ (16)
Common stock dividend declared (14,389)     (14,389)  
Net income 9,812     9,812  
Balance at ending of period (in shares) at Mar. 31, 2025   136,824,000      
Balance at ending of period at Mar. 31, 2025 $ 631,413 $ 14 656,125 11,470 $ (36,196)
Ending balance, treasury stock (in shares) at Mar. 31, 2025         (5,687,000)
Balance at beginning of period (in shares) at Dec. 31, 2024 136,417,677 136,418,000      
Balance at beginning of period at Dec. 31, 2024 $ 635,353 $ 14 655,472 16,047 $ (36,180)
Beginning balance, treasury stock (in shares) at Dec. 31, 2024 (5,683,921)       (5,684,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 34,893        
Balance at ending of period (in shares) at Jun. 30, 2025 136,951,676 136,952,000      
Balance at ending of period at Jun. 30, 2025 $ 642,466 $ 14 656,520 22,128 $ (36,196)
Ending balance, treasury stock (in shares) at Jun. 30, 2025 (5,686,711)       (5,687,000)
Balance at beginning of period (in shares) at Mar. 31, 2025   136,824,000      
Balance at beginning of period at Mar. 31, 2025 $ 631,413 $ 14 656,125 11,470 $ (36,196)
Beginning balance, treasury stock (in shares) at Mar. 31, 2025         (5,687,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Grants of restricted stock (in shares)   218,000      
Forfeitures of restricted stock (in shares)   (90,000)      
Stock-based compensation 395   395    
Common stock dividend declared (14,423)     (14,423)  
Net income $ 25,081     25,081  
Balance at ending of period (in shares) at Jun. 30, 2025 136,951,676 136,952,000      
Balance at ending of period at Jun. 30, 2025 $ 642,466 $ 14 $ 656,520 $ 22,128 $ (36,196)
Ending balance, treasury stock (in shares) at Jun. 30, 2025 (5,686,711)       (5,687,000)